The Valley Desk

NCT06973629 · Interventional trial

Efficacy and Safety of MSC-NTF (NurOwn) in Participants With Early Symptomatic ALS and Moderate Disease Presentation in ALS (ENDURANCE STUDY)

Overall registry status Not yet recruiting

Phase 3

Conditions Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov